Regencell Bioscience Holdings (RGC) Liabilities and Shareholders Equity (2020 - 2025)
Regencell Bioscience Holdings (RGC) posted Liabilities and Shareholders Equity of $3.0 million for Q4 2025, down 47.64% on a QoQ basis from $5.8 million in Q2 2025.
Regencell Bioscience Holdings (RGC) Liabilities and Shareholders Equity (2020 - 2025) Analysis & Trends
Regencell Bioscience Holdings' Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $3.0 million for Q4 2025.
- Quarterly Liabilities and Shareholders Equity changed N/A year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.4 million (changed N/A YoY) and the FY2025 annual result came in at $5.8 million, changed N/A from the prior year.
- Liabilities and Shareholders Equity was $3.0 million for Q4 2025 at Regencell Bioscience Holdings, down from $5.8 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $12.6 million in Q2 2023 and bottomed at $3.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Regencell Bioscience Holdings | 2.78 Bn | 2.78 Bn | - | 3.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.01 Mn |
| Jun 30, 2025 | 5.76 Mn |
| Jun 30, 2023 | 12.62 Mn |
| Jun 30, 2020 | 514,018.00 |